(Q39582724)

13 September 2017

title

Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury (English)

1 reference

13 September 2017

2

1 reference

13 September 2017

Yunfeng Zhou

1

1 reference

13 September 2017

Pan Zhao

3

1 reference

13 September 2017

Hang Yang

4

1 reference

13 September 2017

Lihong Chen

5

1 reference

13 September 2017

Jing Miao

6

1 reference

13 September 2017

Xiaoyan Zhang

7

1 reference

13 September 2017

Jichun Yang

8

1 reference

13 September 2017

Jie Ding

9

1 reference

13 September 2017

Youfei Guan

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

2 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

79

1 reference

13 September 2017

issue

12

1 reference

13 September 2017

page(s)

1302-1311

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2011.17

13 September 2017

exact match

0 references

cites work

Overexpression of cyclooxygenase-2 predisposes to podocyte injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Reactive oxygen species deglycosilate glomerular alpha-dystroglycan.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Inducible rodent models of acquired podocyte diseases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Energy metabolism and cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

The role of PPARs in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

PPARs and the kidney in metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Fibrate prevents cisplatin-induced proximal tubule cell death

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

PPARα ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

PPARalpha protects proximal tubular cells from acute fatty acid toxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

PPARalpha activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

L-carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

An update on the lipid nephrotoxicity hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Renal lipid metabolism and lipotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.17

7 January 2021

Identifiers

DOI

10.1038/KI.2011.17

1 reference

13 September 2017

1 reference